Advisor Resource Council’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,991
Closed -$576K 310
2025
Q1
$576K Buy
+7,991
New +$572K 0.05% 342
2024
Q1
Sell
-7,241
Closed -$552K 326
2023
Q4
$552K Buy
+7,241
New +$504K 0.06% 258
2022
Q3
Sell
-8,104
Closed -$770K 258
2022
Q2
$770K Buy
+8,104
New +$839K 0.07% 232
2022
Q1
Sell
-8,154
Closed -$1.06M 313
2021
Q4
$1.06M Buy
+8,154
New +$951K 0.08% 233
2021
Q3
Sell
-6,881
Closed -$713K 295
2021
Q2
$713K Buy
+6,881
New +$649K 0.07% 248

Other funds holding EW

Advisor Resource Council's EW Position: Q2 2025 in Review

Advisor Resource Council sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 7,991 shares — an estimated $576K sold.

Advisor Resource Council first reported a position in EW in Q2 2021 and held it in 5 quarters. The position peaked at $1.06M in Q4 2021. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Advisor Resource Council reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
  • Advisor Resource Council sold 7,991 Edwards Lifesciences shares in Q2 2025, an estimated $576K.
  • Advisor Resource Council first reported a position in Edwards Lifesciences in Q2 2021 and held it in 5 quarters.
  • Advisor Resource Council's Edwards Lifesciences position peaked at $1.06M in Q4 2021.
  • 1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Advisor Resource Council's 13F filing for Q2 2025, filed 11 Aug 2025.